Metabolites
Profiling Serum Oxylipin Metabolites Across Melanoma Subtypes and Immunotherapy Responders.
Alexander C Goodman, Kylie M Michel, Morgan L MacBeth, Jaqueline A Turner, Richard P Tobin, William A Robinson, Kasey L Couts
Published: 202510.3390/metabo16010014
Abstract
BACKGROUND/OBJECTIVES: Immunotherapy has significantly improved clinical outcomes for patients with late-stage melanoma, yet a substantial portion of patients fail to respond to these treatments. The variability in responses to immunotherapy, both am…
Preview only. Read the full abstract at the source